Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
23 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250723241988/en/Delcath-Systems-to-Host-Second-Quarter-2025-Earnings-Call
22 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250522114364/en/Delcath-Systems-Issues-Full-Year-2025-Guidance
15 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250515839165/en/Delcath-Systems-to-Participate-at-the-Craig-Hallum-22nd-Annual-Investor-Conference
09 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250509201691/en/Delcath-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4
08 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250508705446/en/Delcath-Systems-Reports-First-Quarter-2025-Results-and-Business-Highlights
28 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250428793483/en/Delcath-Systems-Announces-FDA-Clearance-of-IND-Application-for-Phase-2-Clinical-Trial-of-HEPZATO-in-Liver-Dominant-Metastatic-Breast-Cancer
ABOUT THIS PAGE